2010 - 2011 SEMINAR SERIES
10:00am - 11:00am -- H363
Title of presentation
Goal directed therapy in postoperative cardiac surgery - which targets ? Critical Care Medicine, SMBD - Jewish General Hospital and Montreal Chest Institute, Respiratory Epidemiology and Clinical Research Unit, McGill University Tuesday, October 12, 2010 Ilan Matok, MScPharm PhD The BeMORE Collaboration - Using Computerized Databases To Study Drugs Research Fellow, Division of Clinical Pharmacology & Safety During PregnancyToxicologyThe Hospital for Sick Children, Toronto, Ontario Tuesday, October 19, 2010 Lucie Blais, PhD Asthma medications in pregnancy and the risk of congenital malformations Professeure titulaireChaire AstraZeneca en santé respiratoireFaculté de pharmacieUniversité de Montréal Tuesday, October 26, 2010 Samy Suissa, PhD Immortal time bias in observational studies of drug effectiveness James McGill Professor of Epidemiology, Biostatistics and Medicine, McGill UniversityDirector, Centre for Clinical EpidemiologyLady Davis Institute for Medical Research - Jewish General Hospital Evolution in the local treatment of rectal cancer Associate Professor, Department of Oncology, McGill UniversityDirector, Department of Radiation Oncology, Segal Cancer CentreAssistant Chair of Radiation Oncology, McGill University Title of presentation
Tuesday, November 09, 2010Anick Bérard, PhD The Quebec Pregnancy Registry - An opportunity for research in perinatal Director, Research Unit on Medications and Pregnancy pharmacoepidemiologyResearch Center CHU Ste-JustineLouis-Boivin Family Research Chair on Medications, Pregnancy and LactationAssociate Professor, Faculty of Pharmacy, University of MontrealPresident-Elect, Canadian Association for Population Therapeutics Tuesday, November 16, 2010Jim Hanley, PhD Measuring mortality reductions in cancer screening trials Professor, Department of Epidemiology, Biostatistics and Occupational Health,McGill University Tuesday, November 23, 2010Michael Pollak, MD Professor, Department of Medicine & Oncology, McGill UniversityDirector, Cancer Prevention Centre, SMBD-Jewish General HospitalAlexander Goldfarb Research Chair in Medical Oncology Tuesday, November 30, 2010Dr. Bluma Brenner HIV-1 prevention based on molecular epidemiological surveillance of HIV Assistant Professor, Faculty of Surgery (Medicine), McGill UniversityMember, McGill AIDS CentreCo-Coordinator of the Quebec Genotyping ProgramDirector of the Axe de résistance/pathogenèse of the Quebec FRSQ SIDA Network Title of presentation
Tuesday, January 18, 2011 Ian Shrier, MD PhD Dip Sport Med A Causal Diagram Approach to Evidence Synthesis Associate Professor, Department of Family Medicine, McGill UniversityPast-President, Canadian Academy of Sport MedicineInvestigator, Centre for Clinical Epidemiology,SMBD-Jewish General Hospital, LDI Tuesday, January 25, 2011 Mark Wainberg, PhD Sexual Transmission of Drug-Resistant Variants of HIV in Canada and in Developing Countries: Implications for Public Health Lady Davis Institute for Medical Research,Director of the McGill University AIDS Centre Tuesday, February 01, 2011 Helen Trottier, PhD Human Papillomavirus re-infection with the same or a different genotype: the role Assistant Professor, Department of Social and Preventive Medicine, University of Montreal;Researcher, CHU Sainte-Justine Research Center Tuesday, February 08, 2011 Jacques Le Lorier, MD PhD FRCPC FISPE Professor, Departments of Medicine and PharmacologyFaculty of Medicine, University of Montreal;Chief, Pharmacoepidemiology and Pharmacoeconomy Family caregiving for people at the end of life: Tuesday, February 22, 2011 Brett Thombs, PhD The reporting of conflicts of interest in meta-analyses Department of Psychiatry, Lady Davis Institute for Medical Research andMcGill University The Michel Saucier Endowed Chair in Geriatric Pharmacology, Health and AgingAssociate Professor of Medicine University of Montreal, Head, Health Services and Health Promotion research axisCentre de Recherche Institut Universitaire de Gériatrie de Montréal Professor of Medicine, McGill University Development and validation of a clinical prediction Director, Thrombosis Fellowship, McGill University and rule for recurrent venous thromboembolismThrombosis Program, Jewish General Hospital, Division of Internal Medicine, and Centre for Clinical Epidemiology Director, McGill University Office for Science and Society Assistant ProfessorDepartment of Medicine, Faculty Member, Division of Clinical EpidemiologyMcGill University Health Centre CARTaGENE – An infrastructure for research in Findings from screening studies: when do we know enough to implement a new Departments of Obstetrics & Gynecology and (The example of HPV testing for cervical cancer) Preventive & Social Medicine Research Centre, Centre Hospitalier de l'Université de Montréal Long term outcome in ADHD and predictors of outcome Professor of Psychiatry and Pediatrics, Director of Research, Division of Child Psychiatry, McGill University, Montreal Children's Hospital Relationship between Adherence Level to Antihypertensive Agents and Clinical Issues and Healthcare Costs in Real Life Faculté de Pharmacie, Université de MontréalChaire Sanofi Aventis sur l'utilisation des médicaments



12 POSTÊPOWANIE PRZECIWBÓLOWE W URAZACH Ewa Mayzner-Zawadzka, Beata B³aszyk,Wojciech Serednicki, Jan Dobrogowski, Jerzy Wordliczek,Andrzej Zawadzki Obra¿enia cia³a stanowi¹ obecnie jeden z najpowa¿niejszych proble-mów medycznych. S¹ one trzeci¹, co do czêstoœci, przyczyn¹ zgonów,a drug¹, co do czêstoœci, przyczyn¹ niezdolnoœci do pracy. W Polsce wskaŸnik urazowoœci wyno


American Society for Clinical Pharmacology and Therapeutics RIMONABANT PHARMACOKINETICS IN HEALTHY ANDCYP3A5 BUT NOT CYP2D6 POLYMORPHISM AFFECTSOBESE SUBJECTS. S. Turpault, V. Kanamaluru, G. F. Lockwood,DEXTROPROPOXYPHENE DISPOSITION IN HUMAN SUB-D. Bonnet, J. Newton, sanofi-aventis, Malvern, PA. JECTS. M. S. Chow, PharmD, O. Q. Yin, PhD, B. Tomlinson, MD, BACKGROUND: Rimonabant is the fi

© 2010-2017 Pharmacy Pills Pdf